Free Annual ReportsJohnson & Johnson $ 89.91
+0.85
Digital Company Profile
| Last Trade: | 89.91 |
| Trade Time: | Sep 18 06:40 PM Eastern Daylight Time |
| Change: | 0.85 (0.95 %) |
| Prev Close: | 89.06 |
| Open: | 88.91 |
| Bid: | 89.90 |
| Ask: | 89.93 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get JNJ Trend Analysis
-
it has outperformed the S&P 500 by 13%
ETF Alternatives
| Ticker | Name | Weight | % Change |
|---|---|---|---|
| XLV | Health Care Select Sector SPDR | 12.87% | +0.62% |
| IYH | iShares U.S. Healthcare ETF | 11.94% | +0.67% |
| PPH | Market Vectors Pharmaceutical ETF | 11.49% | +1.02% |
| VHT | Vanguard Health Care ETF | 11.17% | +0.59% |
| IHE | iShares U.S. Pharmaceuticals ETF | 10.12% | +0.56% |
| RXL | ProShares Ultra Health Care | 9.09% | +1.28% |
| IXJ | iShares S&P Global Healthcare | 7.94% | +1.21% |
| HDV | iShares High Dividend ETF | 6.83% | +1.33% |
| JKD | iShares Morningstar Large-Cap ETF | 5.76% | +1.17% |
Competitors
| Ticker | Name | Volume | % Change |
|---|---|---|---|
| PFE | Pfizer Inc | 30.22M | +1.40% |
| MRK | Merck & Co Inc | 14.01M | +0.81% |
| BMY | Bristol Myers Squibb Co | 10.39M | +2.47% |
| ELTP | Elite Pharmaceuticals Inc | 9.90M | +21.50% |
| DNDN | Dendreon Corp | 7.33M | +3.51% |
Insider Transactions
| Date | Name | Title | Volume | Trade Price | Holding Change |
|---|---|---|---|---|---|
| 8/14/2013 | COSGROVE STEPHEN J | Corporate Controller | -1,072 | $93.01 | -1.20% |
| 8/14/2013 | COSGROVE STEPHEN J | Corporate Controller | 1,850 | $53.93 | 2.12% |
| 8/14/2013 | COSGROVE STEPHEN J | Corporate Controller | -2,870 | $93.01 | -3.18% |
| 8/14/2013 | COSGROVE STEPHEN J | Corporate Controller | -17,200 | $91.39 | -16.01% |
| 8/14/2013 | COSGROVE STEPHEN J | Corporate Controller | 23,150 | $53.93 | 27.46% |
Data provided by Insiderslab.com.
To read detailed Insider Trading Research Report for (
JNJ ), click here.
JNJ Stock Analysis
-
Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)
-
14 Companies That Have Raised Their Dividends For 50 Years Or More
-
MedTech Industry Stock Update - Sept 2013 - Industry Outlook
-
The Street Has Caught Covidien
-
After A Sharp Pullback, Is Allergan Pretty Enough?
-
Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
-
Free Managed Futures Book
Get the four benefits of managed futures as outlined in this booklet. -
View the Portfolios of the Worlds Top Investors, FREE!
Learn from Warren Buffett, George Soros and More! -
7 Proven Strategies for Market-Stomping Stocks
Discover Investing Strategies that will Benefit Every Investor Today!
Free Annual Reports